In Alzheimer’s disease, brain damage is often linked to a mix of problems, including beta-amyloid buildup, tau pathology, ...
Nia Therapeutics announced that the U.S. Food and Drug Administration has granted Breakthrough Device Designation to its ...
Medical Device Network on MSN
Nia Therapeutics plans FIH memory loss implant trial after FDA green light
Nia Therapeutics' Smart Neurostimulation System (SNS) is the first device to obtain FDA breakthrough designation for memory loss related to moderate-to-severe traumatic brain injury (TBI).
INDIANAPOLIS (WISH) — More than two million Americans will suffer a traumatic brain injury this year. TBI is one of the leading causes of death and disability in the U.S., impacting memory, speech, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results